Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Exclusive - Bayer explores sale of radiology business : sources

Published 17/06/2016, 16:34
© Reuters. The corporate logo of Bayer is seen at the headquarters building in Caracas
BAYGN
-
MON
-

NEW YORK/FRANKFURT (Reuters) - Bayer AG (DE:BAYGn), the German chemicals and healthcare company seeking to acquire Monsanto Co (N:MON), is exploring a sale of its radiology supplies unit that could be worth more than $3 billion (2.10 billion pounds), according to people familiar with the matter.

Bayer has said it that does not need to sell assets to finance its $62 billion bid for Monsanto but had stressed that the strategic reviews of its businesses would continue as usual.

Bayer is in talks with investment banks about hiring a financial adviser to explore strategic alternatives for the radiology supplies business, including a sale, the people said this week. Bayer may decide to keep the unit, the people added.

© Reuters. The corporate logo of Bayer is seen at the headquarters building in Caracas

The sources asked not to be identified because the deliberations are confidential. Bayer declined to comment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.